HEADER TRANSFERASE 03-JUL-18 6GZD TITLE CRYSTAL STRUCTURE OF HUMAN CSNK1A1 WITH A86 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE I ISOFORM ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CKI-ALPHA,CK1; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK1A1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS CKIA, CASEIN KINASE, KINASE INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.BEN-NERIAH,A.VENKATACHALAM,W.MINZEL,A.FINK,I.SNIR-ALKALAY,J.VACCA REVDAT 4 17-JAN-24 6GZD 1 REMARK REVDAT 3 03-OCT-18 6GZD 1 JRNL REVDAT 2 05-SEP-18 6GZD 1 JRNL REVDAT 1 29-AUG-18 6GZD 0 JRNL AUTH W.MINZEL,A.VENKATACHALAM,A.FINK,E.HUNG,G.BRACHYA,I.BURSTAIN, JRNL AUTH 2 M.SHAHAM,A.RIVLIN,I.OMER,A.ZINGER,S.ELIAS,E.WINTER, JRNL AUTH 3 P.E.ERDMAN,R.W.SULLIVAN,L.FUNG,F.MERCURIO,D.LI,J.VACCA, JRNL AUTH 4 N.KAUSHANSKY,L.SHLUSH,M.OREN,R.LEVINE,E.PIKARSKY, JRNL AUTH 5 I.SNIR-ALKALAY,Y.BEN-NERIAH JRNL TITL SMALL MOLECULES CO-TARGETING CKI ALPHA AND THE JRNL TITL 2 TRANSCRIPTIONAL KINASES CDK7/9 CONTROL AML IN PRECLINICAL JRNL TITL 3 MODELS. JRNL REF CELL V. 175 171 2018 JRNL REFN ISSN 1097-4172 JRNL PMID 30146162 JRNL DOI 10.1016/J.CELL.2018.07.045 REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.31 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 3 NUMBER OF REFLECTIONS : 21917 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 1071 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.28 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1603 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.23 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE SET COUNT : 79 REMARK 3 BIN FREE R VALUE : 0.2690 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2456 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 141 REMARK 3 SOLVENT ATOMS : 190 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.21000 REMARK 3 B22 (A**2) : -0.21000 REMARK 3 B33 (A**2) : 0.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.214 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.186 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2723 ; 0.008 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2597 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3617 ; 1.182 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6018 ; 3.585 ; 2.985 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 307 ; 5.586 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 128 ;35.433 ;22.812 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 483 ;13.346 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;11.595 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 365 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2892 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 582 ; 0.006 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1220 ; 4.327 ; 5.495 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1221 ; 4.325 ; 5.496 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1526 ; 6.226 ; 8.231 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1527 ; 6.224 ; 8.231 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1503 ; 5.056 ; 6.067 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1504 ; 5.055 ; 6.068 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2088 ; 7.515 ; 8.805 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2955 ; 9.954 ;60.202 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2927 ; 9.949 ;59.946 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6GZD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-JUL-18. REMARK 100 THE DEPOSITION ID IS D_1200010751. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-17 REMARK 200 TEMPERATURE (KELVIN) : 100.5 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.966 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22991 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280 REMARK 200 RESOLUTION RANGE LOW (A) : 29.310 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 5FQD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CSNK1A1 AT A CONCENTRATION OF 5.8 REMARK 280 MG/ML (50 MM TRIS-HCL, 300 MM NACL, 0.25 MM TCEP, PH 8.0) WAS REMARK 280 PRE-INCUBATED WITH 0.7 MM (4.7-FOLD MOLAR EXCESS) OF MG2+-ATP REMARK 280 (120 MM IN UPW) FOR 1 H. 0.1 UL OF THE PROTEIN SOLUTION WAS THEN REMARK 280 MIXED WITH 0.1 UL OF RESERVOIR SOLUTION (0.10 M MES/NAOH PH 6.8, REMARK 280 10.0% 2-PROPANOL, 26.0% PEG400) AND EQUILIBRATED AT 4 C OVER REMARK 280 0.06ML OF RESERVOIR SOLUTION. WELL DIFFRACTING CRYSTALS APPEARED REMARK 280 WITHIN 4 DAYS AND GREW TO FULL SIZE OVER 23 DAYS., VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 3555 -Y,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X,Z+3/4 REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X,-Y,Z REMARK 290 7555 -Y+1/2,X,Z+3/4 REMARK 290 8555 Y,-X+1/2,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 56.69150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 56.69150 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.43900 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 56.69150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 20.21950 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 56.69150 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 60.65850 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 56.69150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 56.69150 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 40.43900 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 56.69150 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 60.65850 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 56.69150 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 20.21950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -36 REMARK 465 GLY A -35 REMARK 465 SER A -34 REMARK 465 SER A -33 REMARK 465 HIS A -32 REMARK 465 HIS A -31 REMARK 465 HIS A -30 REMARK 465 HIS A -29 REMARK 465 HIS A -28 REMARK 465 HIS A -27 REMARK 465 SER A -26 REMARK 465 SER A -25 REMARK 465 GLY A -24 REMARK 465 VAL A -23 REMARK 465 ASP A -22 REMARK 465 LEU A -21 REMARK 465 TRP A -20 REMARK 465 SER A -19 REMARK 465 HIS A -18 REMARK 465 PRO A -17 REMARK 465 GLN A -16 REMARK 465 PHE A -15 REMARK 465 GLU A -14 REMARK 465 LYS A -13 REMARK 465 GLY A -12 REMARK 465 THR A -11 REMARK 465 GLU A -10 REMARK 465 ASN A -9 REMARK 465 LEU A -8 REMARK 465 TYR A -7 REMARK 465 PHE A -6 REMARK 465 GLN A -5 REMARK 465 GLY A -4 REMARK 465 GLY A -3 REMARK 465 GLY A -2 REMARK 465 GLY A -1 REMARK 465 ARG A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 SER A 5 REMARK 465 GLY A 6 REMARK 465 SER A 7 REMARK 465 LYS A 8 REMARK 465 ALA A 306 REMARK 465 GLN A 307 REMARK 465 GLN A 308 REMARK 465 ALA A 309 REMARK 465 ALA A 310 REMARK 465 SER A 311 REMARK 465 SER A 312 REMARK 465 SER A 313 REMARK 465 GLY A 314 REMARK 465 GLN A 315 REMARK 465 GLY A 316 REMARK 465 GLN A 317 REMARK 465 GLN A 318 REMARK 465 ALA A 319 REMARK 465 GLN A 320 REMARK 465 THR A 321 REMARK 465 PRO A 322 REMARK 465 THR A 323 REMARK 465 GLY A 324 REMARK 465 LYS A 325 REMARK 465 GLN A 326 REMARK 465 THR A 327 REMARK 465 ASP A 328 REMARK 465 LYS A 329 REMARK 465 THR A 330 REMARK 465 LYS A 331 REMARK 465 SER A 332 REMARK 465 ASN A 333 REMARK 465 MET A 334 REMARK 465 LYS A 335 REMARK 465 GLY A 336 REMARK 465 PHE A 337 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 16 -4.42 -163.10 REMARK 500 ALA A 52 -145.42 -154.81 REMARK 500 HIS A 54 91.25 -178.91 REMARK 500 LYS A 83 -122.18 58.95 REMARK 500 ASP A 136 57.43 -154.22 REMARK 500 ASP A 157 86.44 70.46 REMARK 500 ARG A 170 19.64 59.91 REMARK 500 THR A 217 -18.63 82.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1289 DISTANCE = 6.62 ANGSTROMS REMARK 525 HOH A1290 DISTANCE = 7.55 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PGE A 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PGE A 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PGE A 1005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1008 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1009 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 1011 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 1012 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 1013 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 1014 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 1015 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 1016 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TCE A 1017 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LCI A 1018 DBREF 6GZD A 1 337 UNP P48729 KC1A_HUMAN 1 337 SEQADV 6GZD MET A -36 UNP P48729 INITIATING METHIONINE SEQADV 6GZD GLY A -35 UNP P48729 EXPRESSION TAG SEQADV 6GZD SER A -34 UNP P48729 EXPRESSION TAG SEQADV 6GZD SER A -33 UNP P48729 EXPRESSION TAG SEQADV 6GZD HIS A -32 UNP P48729 EXPRESSION TAG SEQADV 6GZD HIS A -31 UNP P48729 EXPRESSION TAG SEQADV 6GZD HIS A -30 UNP P48729 EXPRESSION TAG SEQADV 6GZD HIS A -29 UNP P48729 EXPRESSION TAG SEQADV 6GZD HIS A -28 UNP P48729 EXPRESSION TAG SEQADV 6GZD HIS A -27 UNP P48729 EXPRESSION TAG SEQADV 6GZD SER A -26 UNP P48729 EXPRESSION TAG SEQADV 6GZD SER A -25 UNP P48729 EXPRESSION TAG SEQADV 6GZD GLY A -24 UNP P48729 EXPRESSION TAG SEQADV 6GZD VAL A -23 UNP P48729 EXPRESSION TAG SEQADV 6GZD ASP A -22 UNP P48729 EXPRESSION TAG SEQADV 6GZD LEU A -21 UNP P48729 EXPRESSION TAG SEQADV 6GZD TRP A -20 UNP P48729 EXPRESSION TAG SEQADV 6GZD SER A -19 UNP P48729 EXPRESSION TAG SEQADV 6GZD HIS A -18 UNP P48729 EXPRESSION TAG SEQADV 6GZD PRO A -17 UNP P48729 EXPRESSION TAG SEQADV 6GZD GLN A -16 UNP P48729 EXPRESSION TAG SEQADV 6GZD PHE A -15 UNP P48729 EXPRESSION TAG SEQADV 6GZD GLU A -14 UNP P48729 EXPRESSION TAG SEQADV 6GZD LYS A -13 UNP P48729 EXPRESSION TAG SEQADV 6GZD GLY A -12 UNP P48729 EXPRESSION TAG SEQADV 6GZD THR A -11 UNP P48729 EXPRESSION TAG SEQADV 6GZD GLU A -10 UNP P48729 EXPRESSION TAG SEQADV 6GZD ASN A -9 UNP P48729 EXPRESSION TAG SEQADV 6GZD LEU A -8 UNP P48729 EXPRESSION TAG SEQADV 6GZD TYR A -7 UNP P48729 EXPRESSION TAG SEQADV 6GZD PHE A -6 UNP P48729 EXPRESSION TAG SEQADV 6GZD GLN A -5 UNP P48729 EXPRESSION TAG SEQADV 6GZD GLY A -4 UNP P48729 EXPRESSION TAG SEQADV 6GZD GLY A -3 UNP P48729 EXPRESSION TAG SEQADV 6GZD GLY A -2 UNP P48729 EXPRESSION TAG SEQADV 6GZD GLY A -1 UNP P48729 EXPRESSION TAG SEQADV 6GZD ARG A 0 UNP P48729 EXPRESSION TAG SEQADV 6GZD GLY A 20 UNP P48729 VAL 20 CONFLICT SEQADV 6GZD THR A 35 UNP P48729 ILE 35 CONFLICT SEQADV 6GZD HIS A 58 UNP P48729 LEU 58 CONFLICT SEQRES 1 A 374 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 374 VAL ASP LEU TRP SER HIS PRO GLN PHE GLU LYS GLY THR SEQRES 3 A 374 GLU ASN LEU TYR PHE GLN GLY GLY GLY GLY ARG MET ALA SEQRES 4 A 374 SER SER SER GLY SER LYS ALA GLU PHE ILE VAL GLY GLY SEQRES 5 A 374 LYS TYR LYS LEU GLY ARG LYS ILE GLY SER GLY SER PHE SEQRES 6 A 374 GLY ASP ILE TYR LEU ALA THR ASN ILE THR ASN GLY GLU SEQRES 7 A 374 GLU VAL ALA VAL LYS LEU GLU SER GLN LYS ALA ARG HIS SEQRES 8 A 374 PRO GLN LEU HIS TYR GLU SER LYS LEU TYR LYS ILE LEU SEQRES 9 A 374 GLN GLY GLY VAL GLY ILE PRO HIS ILE ARG TRP TYR GLY SEQRES 10 A 374 GLN GLU LYS ASP TYR ASN VAL LEU VAL MET ASP LEU LEU SEQRES 11 A 374 GLY PRO SER LEU GLU ASP LEU PHE ASN PHE CYS SER ARG SEQRES 12 A 374 ARG PHE THR MET LYS THR VAL LEU MET LEU ALA ASP GLN SEQRES 13 A 374 MET ILE SER ARG ILE GLU TYR VAL HIS THR LYS ASN PHE SEQRES 14 A 374 ILE HIS ARG ASP ILE LYS PRO ASP ASN PHE LEU MET GLY SEQRES 15 A 374 ILE GLY ARG HIS CYS ASN LYS LEU PHE LEU ILE ASP PHE SEQRES 16 A 374 GLY LEU ALA LYS LYS TYR ARG ASP ASN ARG THR ARG GLN SEQRES 17 A 374 HIS ILE PRO TYR ARG GLU ASP LYS ASN LEU THR GLY THR SEQRES 18 A 374 ALA ARG TYR ALA SER ILE ASN ALA HIS LEU GLY ILE GLU SEQRES 19 A 374 GLN SER ARG ARG ASP ASP MET GLU SER LEU GLY TYR VAL SEQRES 20 A 374 LEU MET TYR PHE ASN ARG THR SER LEU PRO TRP GLN GLY SEQRES 21 A 374 LEU LYS ALA ALA THR LYS LYS GLN LYS TYR GLU LYS ILE SEQRES 22 A 374 SER GLU LYS LYS MET SER THR PRO VAL GLU VAL LEU CYS SEQRES 23 A 374 LYS GLY PHE PRO ALA GLU PHE ALA MET TYR LEU ASN TYR SEQRES 24 A 374 CYS ARG GLY LEU ARG PHE GLU GLU ALA PRO ASP TYR MET SEQRES 25 A 374 TYR LEU ARG GLN LEU PHE ARG ILE LEU PHE ARG THR LEU SEQRES 26 A 374 ASN HIS GLN TYR ASP TYR THR PHE ASP TRP THR MET LEU SEQRES 27 A 374 LYS GLN LYS ALA ALA GLN GLN ALA ALA SER SER SER GLY SEQRES 28 A 374 GLN GLY GLN GLN ALA GLN THR PRO THR GLY LYS GLN THR SEQRES 29 A 374 ASP LYS THR LYS SER ASN MET LYS GLY PHE HET DMS A1001 4 HET DMS A1002 4 HET PGE A1003 10 HET PGE A1004 10 HET PGE A1005 10 HET EDO A1006 4 HET EDO A1007 4 HET EDO A1008 4 HET EDO A1009 4 HET EDO A1010 4 HET PEG A1011 7 HET PEG A1012 7 HET PEG A1013 7 HET PEG A1014 7 HET PEG A1015 7 HET PEG A1016 7 HET TCE A1017 32 HET LCI A1018 25 HETNAM DMS DIMETHYL SULFOXIDE HETNAM PGE TRIETHYLENE GLYCOL HETNAM EDO 1,2-ETHANEDIOL HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM TCE 3,3',3''-PHOSPHANETRIYLTRIPROPANOIC ACID HETNAM LCI [4-[[4-[5-(CYCLOPROPYLMETHYL)-1-METHYL-PYRAZOL-4-YL]-5- HETNAM 2 LCI FLUORANYL-PYRIMIDIN-2-YL]AMINO]CYCLOHEXYL]AZANIUM HETSYN EDO ETHYLENE GLYCOL HETSYN TCE 3-[BIS(2-CARBOXYETHYL)PHOSPHANYL]PROPANOIC ACID FORMUL 2 DMS 2(C2 H6 O S) FORMUL 4 PGE 3(C6 H14 O4) FORMUL 7 EDO 5(C2 H6 O2) FORMUL 12 PEG 6(C4 H10 O3) FORMUL 18 TCE C9 H15 O6 P FORMUL 19 LCI C18 H26 F N6 1+ FORMUL 20 HOH *190(H2 O) HELIX 1 AA1 GLN A 56 GLN A 68 1 13 HELIX 2 AA2 SER A 96 CYS A 104 1 9 HELIX 3 AA3 THR A 109 LYS A 130 1 22 HELIX 4 AA4 LYS A 138 ASP A 140 5 3 HELIX 5 AA5 ILE A 146 CYS A 150 5 5 HELIX 6 AA6 SER A 189 LEU A 194 1 6 HELIX 7 AA7 SER A 199 THR A 217 1 19 HELIX 8 AA8 THR A 228 THR A 243 1 16 HELIX 9 AA9 PRO A 244 CYS A 249 1 6 HELIX 10 AB1 PRO A 253 LEU A 266 1 14 HELIX 11 AB2 ASP A 273 LEU A 288 1 16 HELIX 12 AB3 PHE A 296 ALA A 305 1 10 SHEET 1 AA1 6 ILE A 12 VAL A 13 0 SHEET 2 AA1 6 TYR A 17 SER A 25 -1 O TYR A 17 N VAL A 13 SHEET 3 AA1 6 ASP A 30 ASN A 36 -1 O LEU A 33 N GLY A 20 SHEET 4 AA1 6 GLU A 42 SER A 49 -1 O VAL A 45 N TYR A 32 SHEET 5 AA1 6 TYR A 85 ASP A 91 -1 O ASN A 86 N GLU A 48 SHEET 6 AA1 6 ILE A 76 GLU A 82 -1 N GLY A 80 O VAL A 87 SHEET 1 AA2 2 PHE A 132 ILE A 133 0 SHEET 2 AA2 2 LYS A 162 LYS A 163 -1 O LYS A 162 N ILE A 133 SHEET 1 AA3 2 PHE A 142 MET A 144 0 SHEET 2 AA3 2 LEU A 153 LEU A 155 -1 O PHE A 154 N LEU A 143 SITE 1 AC1 3 ARG A 135 LYS A 179 DMS A1002 SITE 1 AC2 4 ARG A 135 LEU A 160 ALA A 161 DMS A1001 SITE 1 AC3 5 PRO A 220 LYS A 239 SER A 242 THR A 243 SITE 2 AC3 5 HOH A1201 SITE 1 AC4 8 GLN A 119 TYR A 175 ASN A 191 ARG A 201 SITE 2 AC4 8 ARG A 267 TYR A 294 HOH A1103 HOH A1142 SITE 1 AC5 4 ASN A 261 GLN A 291 ASP A 293 HOH A1251 SITE 1 AC6 6 ASP A 118 SER A 122 TYR A 175 HOH A1142 SITE 2 AC6 6 HOH A1175 HOH A1204 SITE 1 AC7 1 TYR A 59 SITE 1 AC8 2 ARG A 170 GLN A 171 SITE 1 AC9 2 TYR A 262 ASP A 273 SITE 1 AD1 4 ASP A 166 GLN A 171 HIS A 172 ILE A 173 SITE 1 AD2 4 THR A 169 ARG A 170 MET A 275 GLN A 279 SITE 1 AD3 4 TYR A 126 LYS A 130 ARG A 176 HOH A1149 SITE 1 AD4 2 PHE A 11 TYR A 85 SITE 1 AD5 4 ASP A 178 LYS A 179 HIS A 193 LEU A 194 SITE 1 AD6 10 THR A 184 ALA A 185 ARG A 186 TRP A 221 SITE 2 AD6 10 GLN A 222 GLY A 223 LEU A 224 LYS A 232 SITE 3 AD6 10 ILE A 236 HOH A1156 SITE 1 AD7 10 SER A 25 GLY A 26 ILE A 31 ALA A 44 SITE 2 AD7 10 MET A 90 ASP A 91 LEU A 93 GLY A 94 SITE 3 AD7 10 ASP A 99 LEU A 143 CRYST1 113.383 113.383 80.878 90.00 90.00 90.00 I 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008820 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008820 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012364 0.00000